Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BNTX stock hub

BioNTech SE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BNTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BNTX

In the news

Latest news · BNTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-6.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-25.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BNTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

EUR

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001776985
Company name	BioNTech SE
Country	Germany
Country code	US
Cusip	09075V102
Employees	7,807
Employees Change	1,035%
Employees Change Percent	15.28
Enterprise value	$8.3B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-10
Isin	US09075V1026
Last refreshed	2026-05-10
Market cap	$23.8B
Market cap category	Large-Cap
Price	$94.13
Price currency	USD
Rev Per Employee	414,295.58x
Sector	Healthcare
Sic	2836
Symbol	BNTX
Website	https://www.biontech.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.07%
EV/FCF	11.19x
EV/Sales	2.58x
FCF yield	3.13%
P/B ratio	1.1x
P/S ratio	7.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-50.35%
EBITDA Margin	-42.47%
FCF margin	23.07%
Gross margin	78.65%
Gross Profit	$2.5B
Gross Profit Growth	1.19%
Gross Profit Growth Q	-52.83%
Gross Profit Growth3 Y	-40.39%
Gross Profit Growth5 Y	-0.09%
Net Income	$-1.4B
Net Income Growth Years	0%
Pretax Margin	-41.83%
Profit Margin	-44.64%
Profit Per Employee	$-184,935
ROA	-4.18
Roa5y	27.18
ROCE	-7.31
ROE	-6.66
Roe5y	41.92
ROIC	-25.58
Roic5y	51.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1.43%
Cagr3y	-4.61%
Cagr5y	-12.35%
EPS Growth Years	0
FCF Growth3 Y	-57.97%
OCF Growth3 Y	-54.83%
Revenue Growth	2.15x
Revenue Growth Q	-35.39x
Revenue Growth Years	1x
Revenue Growth3 Y	-38.76x
Revenue Growth5 Y	2.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.13
Assets	$24.3B
Cash	$15.8B
Current Assets	$18.3B
Current Liabilities	$2.1B
Debt	$349.1M
Debt Equity	$0.02
Debt FCF	$0.47
Equity	$21.6B
Interest Coverage	-97.41
Liabilities	$2.7B
Long Term Assets	$6B
Long Term Liabilities	$658.4M
Net Cash	$15.5B
Net Cash By Market Cap	$64.93
Net Cash Growth	-0.22%
Net Debt Equity	$-0.72
Net Debt FCF	$-20.71
Tangible Book Value	$19.3B
Tangible Book Value Per Share	$76.51
WACC	11.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.8
Inventory Turnover	3.34
Net Working Capital	$134.8M
Quick ratio	8.11
Working Capital	$15.9B
Working Capital Turnover	$0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.91%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1.55

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1.43%
200-day SMA	102.2
3Y total return	-13.19%
50-day SMA	96.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-48.27%
All Time High	464
All Time High Change	-79.71%
All Time High Date	2021-08-10
All Time Low	12.53
All Time Low Change	651.5%
All Time Low Date	2019-10-14
ATR	4.03
Beta	1.37
Beta1y	1.1
Beta2y	1.14
Ch YTD	-1.13
High	95.99
High52	124
High52 Date	2026-01-22
High52ch	-24.09%
Low	92.5
Low52	79.52
Low52 Date	2026-03-10
Low52ch	18.37%
Ma50ch	-2.16%
Premarket Change Percent	-0.38
Premarket Price	$92.67
Premarket Volume	8,529
Price vs 200-day SMA	-7.92%
RSI	42.36
RSI Monthly	45.88
RSI Weekly	45
Sharpe ratio	0.17x
Sortino ratio	0.38
Total Return	-1.91%
Tr YTD	-1.13
Tr1m	5.03%
Tr1w	-3.5%
Tr3m	-11.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	6
Analyst Price Target Top	$129
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-2.52
Earnings Revenue Estimate	214,620,000x
Earnings Revenue Estimate Growth	11.65x
Operating Income	$-1.6B
Operating margin	-50.35
Price target	$132
Price Target Change	$39.91
Price Target Change Top	$37.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109,300,437%
Float Percent	43.22%
Net Borrowing	-12,618,490
Shares Insiders	16.73%
Shares Institutions	20.1%
Shares Out	252,884,261
Shares Qo Q	3.81%
Shares Yo Y	1.91%
Short Ratio	3.48
Short Shares	4.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$650.3M
Average Volume	992,648.35x
Bv Per Share	85.25
CAPEX	$-211M
Ch1m	5.03
Ch1w	-3.5
Ch1y	1.43
Ch3m	-11.72
Ch3y	-13.19
Ch5y	-48.76
Ch6m	-8.74
Change	1.19%
Change From Open	0.8
Close	93.02
Days Gap	0.39
Depreciation Amortization	260,742,816.3
Dollar Volume	97,468,978.9
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-1.6B
EBITDA	$-1.4B
EPS	$-5.89
F Score	3
FCF	$746.1M
FCF EV Yield	8.94x
FCF Per Share	$2.95
Financing CF	-14,643,145
Fiscal Year End	December
Founded	2,008
Goodwill	436,929,956.8
Income Tax	$90.7M
Investing CF	-1,227,602,905
Ipr	527.5
Iprfo	470.5
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	101.1
Ma150ch	-6.93%
Ma20	101
Ma20ch	-6.81%
Net CF	-283,062,377
Next Earnings Date	2026-08-03
Open	93.38
Optionable	Yes
P FCF Ratio	31.9
P OCF Ratio	25.31
Position In Range	46.56
Post Close	94.13
Postmarket Change Percent	1.47
Postmarket Price	$95.51
Ppne	1,554,550,793.5
Pre Close	93.02
Price Date	2026-05-08
Ptbv Ratio	1.23
Relative Volume	1.04x
Revenue	3,234,405,626x
SBC By Revenue	2.96x
Share Based Comp	95,814,597
Tax By Revenue	2.81x
Tr6m	-8.74%
Volume	1,035,527
Z Score	7.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BNTX pay a dividend?

Capital-return profile for this ticker.

Performance

BNTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BNTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.1%

Float: +43.2% of shares outstanding

Insider ownership

+16.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BNTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.4

Neutral momentum band

Price vs 200-day MA

-7.9%

50/200-day relationship not available

Beta (5Y)

1.37

More volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BNTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BNTX stock rating?

BioNTech SE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BNTX analysis?

The full report lives at /stocks/BNTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BNTX?

The latest report frames BNTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BNTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.